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Background: Epidemiological estimates of left ventricular mass are based on echocardiographic imaging from the parasternal view, which
is often unavailable in subjects with obesity or lung disease. This study was undertaken to assess whether the subcostal view is a valid
alternative to estimate left ventricular mass in an unselected older population. Methods: In a cross-sectional study of all the residents in
Dicomano, Italy, aged z 65 years, echocardiography was performed with a systematic attempt to obtain both the parastermal and the
subcostal views. Results: The parasternal view was missing in 73/614 participants, 48 of whom were imaged from the subcostal view. In
participants imaged from both views, the subcostal view underestimated left ventricular cavity dimension and, consequently, left ventricular
mass [79.7 (1.3) vs. 93.3 (1.5) g/m2; p < 0.001]. Furthermore, the subcostal view was only 25% sensitive for the diagnosis of hypertrophy.
Several multivariate regression models, developed in an equation development subgroup and tested in a validation subgroup, failed to correct
the prediction of left ventricular mass based on measures taken from the subcostal view, also after inclusion of demographic, anthropometric,
and spirometric covariates. Conclusions: In unselected older persons, the subcostal view does not improve the accuracy of echocardiographic
estimation of left ventricular mass, which remains biased in epidemiological studies.
D 2004 Elsevier Ireland Ltd. All rights reserved.Keywords: Epidemiology; Validity; Population studies; Echocardiography; LV hypertrophy; Aging
1. Introduction obese or have pulmonary disease [10,11]. This limitationLeft ventricular hypertrophy is a powerful, independent
predictor of cardiovascular morbidity and mortality in
patients with high blood pressure and other conditions
[1–4]. Two-dimensional guided M-mode echocardiography
from the parasternal approach is the standardized technique
of choice to quantitate left ventricular mass and diagnose
left ventricular hypertrophy [5]. Echocardiographic meas-
ures of left ventricular mass are reliable, reproducible [6,7],
and predictive of subsequent outcomes [3,8,9].
However, the quality of echocardiographic images from
the parasternal view is often poor in persons who are older,0167-5273/$ - see front matter D 2004 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.ijcard.2003.12.021
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E-mail address: dibari@unifi.it (M. Di Bari).may be particularly problematic in epidemiological studies
of older populations. For instance, due to this, in the
Cardiovascular Health Study (CHS), the echocardiographic
estimation of left ventricular mass was unavailable in 34%
of 5201 participants aged 65 years and older. Measurements
of left ventricular mass were selectively missing in male
participants who were older, heavier and taller, or had a
history of coronary artery disease, hypertension, and diabe-
tes [10,12], all conditions that are associated with an
increased left ventricular mass.
Thus, such selective data loss could significantly bias
the echocardiographic estimate of the prevalence of left
ventricular hypertrophy and the risk associated with it
[11]. Magnetic resonance imaging provides highly accu-
rate estimates of left ventricular mass [13], but because of
its costs and poor transportability, it is unlikely that it
M. Di Bari et al. / International Journal of Cardiology 97 (2004) 521–527522could substitute echocardiography in large epidemiological
studies.
For clinical purposes, the subcostal view is commonly
used as an alternative to the standard parasternal view [14].
However, comparisons between measures of left ventricular
mass obtained from the parasternal and the subcostal views
have been conducted only in small clinical series, with
conflicting results [15,16]. We conducted this study to
determine whether the subcostal view is a reliable alterna-
tive for the echocardiographic measurement of left ventric-
ular mass in epidemiological studies when the parasternal
approach is unavailable.Table 1
Characteristics of the 614 study participants
Mean (S.E.M.) N (%)
Age (years) 73.4 (0.25) (range: 65–94)
Male gender 256 (41.7)
Body height (cm) 157.4 (0.37)
Body weight (kg) 67.4 (0.51)
Body mass index (kg/m2) 27.2 (0.18)
Waist circumference (cm) 94.3 (0.47)
Coronary artery disease 96 (15.7)
Hypertension 441 (71.8)
Smoking (current or past) 264 (43.0)






63 (10.3)2. Materials and methods
2.1. Study population and protocol
This study is part of an epidemiological survey on heart
failure in the elderly (‘‘Insufficienza Cardiaca negli Anziani
Residenti a Dicomano’’, ICARe Dicomano Study), which
enrolled the entire home-dwelling, elderly (z 65 years)
population recorded in the City Registry Office of Dico-
mano, Italy. The design of the study, which followed the
principles outlined in the Declaration of Helsinki on bio-
medical research involving human subjects, have been
published elsewhere [17].
2.2. Data collection
After informed consent, participants received a complete
clinical exam, 12-lead EKG, M-mode, two-dimensional and
color Doppler echocardiography, and spirometry. Body
height (cm) and weight (kg), and waist circumference
(cm) were measured. Hypertension was defined as a blood
pressure of >140/90 mm Hg, or drug treatment [18]. History
and EKG criteria were used to define the presence of
coronary artery disease, which included previous myocar-
dial infarction (medical records or typical symptoms asso-
ciated with EKG changes), angina (typical chest pain, as
assessed with Rose questionnaire, or positive stress test),
and myocardial revascularization procedures (medical
records).[17] The Minnesota coding system was used to
define left ventricular hypertrophy on EKG (codes 3–1, 3–
3, and 3–4).[19] Smoking status was classified as previous
or current smoker versus never smoker.
2.3. Echocardiographic examination
Echocardiography was performed with a mechanical
sector scanner (Challenger, 3.5–2.5 MHz dynamically fo-
cused transducer, ESAOTE Biomedica). In all cases,
attempts were made at visualizing the left ventricular
chamber from both the parasternal and subcostal
approaches. Images from the parasternal view were obtained
at expiratory apnea in the left decubitus position, whereassubcostal images were obtained at deep inspiratory apnea in
the supine position.
In both the parasternal and the subcostal views, orienta-
tion of the ultrasound beam was optimized in two-dimen-
sional long-and short-axis images. Two-dimensionally
guided M-mode images were videotaped and stop frame
images were digitized (TomTecP90 System, TomTec Imag-
ing Systems) for quantitative analysis. The criteria proposed
by Schieken [20] were used to judge technical acceptability
of M-mode images from either parasternal or subcostal
view. As commonly accepted [5,21], linear measures were
taken from parasternal two-dimensional images when M-
mode orientation was suboptimal (less than 10% of cases).
Left ventricular wall thickness and internal dimensions
were measured according to the American Society of Echo-
cardiography (ASE) convention [22]; at least three to five
measures were averaged in participants in sinus and non-
sinus rhythm, respectively. Left ventricular mass was calcu-
lated by the adjusted ASE method and left ventricular
hypertrophy was defined as left ventricular mass/body sur-
face area >116 g/m2 in men and >104 g/m2 in women [23].
Regional wall motion abnormalities were scored semi-
quantitatively as hypokinesia, akinesia, or dyskynesia on
the basis of reduced, absent, or paradoxical endocardial
motion and myocardial thickening of 16 left ventricular
segments.
2.4. Spirometry
Pulmonary functional assessment was performed with
standard spirometric methods [24]. Forced vital capacity
(FVC), forced expiratory volume in 1 s (FEV1), expressed
as percent of predicted values [25], and their ratio (FEV1/
FVC) was used to diagnose obstructive lung disease.
2.5. Analytic procedures
Statistical analysis was performed with the SPSS for
Windows 10.1 package. Mean values are expressed as mean
Fig. 1. Availability of parasternal and subcostal views in the study
participants.
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test, where continuous anthropometric variables were cate-
gorized into tertiles. Logistic regression was used to identify
the independent predictors of a missing left ventricular mass
value. To this purpose, candidate predictors were considered
all the variables that in bivariate comparisons tended to be
associated with the outcome ( p < 0.1). Redundant variables
were backward deleted from a complete initial model, to
obtain a final parsimonious model of prediction.
Left ventricular mass estimates and the corresponding
measures from the parasternal and subcostal approaches
were compared using the paired t test in the 323 participants
who had both views available. The comparison was then
restricted to the 282 participants in this group who were in
sinus rhythm and had no left ventricular wall motion
abnormalities. Because left ventricular mass differed signif-
icantly between the two views, multivariate regression
analyses were used to adjust the original subcostal estimate.
To this purpose, the 282 participants were randomly
assigned to an equation development subgroup (n = 146)
and a cross-validation subgroup (n = 136), where spiromet-Table 2
Factors associated with a missing mass value
Parasternal view




Age (years) 65–74 39 (9.7) 1.0
75–84 21 (12.5) 1.3
z85 13 (31.0) 4.2
Male gender No 30 (8.4) 1.0
Yes 43 (16.8) 2.2
Body mass index (kg/m2) < 25.1 19 (9.3) 1.0
25.1–28.5 22 (10.8) 1.2
z 28.5 30 (14.7) 1.7
Waist circumference (cm) < 90 14 (7.0) 1.0
90–99 26 (12.2) 1.8
z99 32 (16.0) 2.5
Current/past smoking No 27 (7.7) 1.0
Yes 46 (17.4) 2.5
Obstructive lung disease No 38 (9.3) 1.0
Yes 21 (16.7) 2.0
*p< 0.01 vs. first tertile.
**p< 0.05 vs. first tertile.
***p< 0.001 vs. No.ric data were missing in 13 and 6 participants, respectively.
Equations were developed and validated either predicting
directly the parasternal view left ventricular mass from the
subcostal mass estimate, or predicting the parasternal left
ventricular diastolic dimension from the subcostal measure
and then using this adjusted value to recalculate left ven-
tricular mass. In both sets of equations, age, gender, height,
weight (or, alternatively, waist circumference), and spiro-
metric data were entered stepwise as covariates, with p
values of < 0.05 for entry and of < 0.1 for exiting variables.
Competitive models were compared in terms of their
explained variance (unadjusted R2 value). Predictive equa-
tions were validated in the cross-validation subgroup by
regressing the predicted values on the corresponding values
measured from the parasternal view, and assessing whether
the slope and the intercept of the regression equation
differed significantly from one and zero, respectively. Fi-
nally, the difference between observed and predicted values
was regressed on the observed parasternal values. A two-
tailed p value < 0.05 was considered statistically significant.3. Results
As of April 25, 1995, there were 899 residents in
Dicomano aged 65 years and over, of whom 864 were
initially eligible. Of them, 614 were included in the present
study, whereas 21 died or were institutionalized before data
collection and 229 refused to participate. Mean age of
eligible persons who did and did not participate in the
cardiopulmonary assessment was 73.4 (0.3) and 75.8 (0.5)
years ( p < 0.001), with almost an even distribution of non-Subcostal view
95% Confidence
interval






– 153 (37.9) 1.0 –
0.8, 2.4 70 (41.7) 1.2 0.8, 1.7
2.0, 8.7* 20 (47.6) 1.5 0.8, 2.8
p for trend < 0.001
– 143 (39.9) 1.0 –
1.3, 3.6*** 100 (39.1) 1.0 0.7, 1.3
– 69 (33.8) 1.0 –
0.6, 2.2 82 (40.2) 1.3 0.9–2.0
0.9, 3.1 90 (44.1) 1.5 1.0, 2.3**
– 69 (34.7) 1.0 –
0.9, 3.6 83 (39.0) 1.2 0.8–1.8
1.3, 4.9* 89 (44.5) 1.5 1.0, 2.3**
p for trend = 0.024
– 145 (41.4) 1.0 –
1.5, 4.2*** 98 (37.1) 0.8 0.6, 1.2
– 152 (37.2) 1.0 –
1.1, 3.5*** 46 (36.5) 1.0 0.6, 1.5
Fig. 2. Paired comparisons of M-mode echocardiographic parameters from
the parasternal view (solid bars) and the subcostal view (open bars) in 282
participants. SDT: ventricular septum diastolic thickness, LVDD: left
ventricular diastolic dimension, FWDT: free wall diastolic thickness.
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p = 0.205).
The principal characteristics of the study population are
summarized in Table 1. As reported in Fig. 1, the parasternal
view was inadequate to obtain a measurable left ventricular
imaging in 73 participants (11.9%). Age, male gender,
smoking, larger waist circumference, and obstructive lung
physiology (but not body weight and height, history of
hypertension and of coronary artery disease, and presence of
wall motion abnormalities; data not shown) were bivariate
predictors of missing left ventricular mass values from the
parasternal view (Table 2). All the candidate predictors,
identified from bivariate associations ( p < 0.1) where en-
tered in a multivariate logistic regression model; after
backward deletion of redundant variables, smoking, age,
and waist circumference remained the only independent
predictors of a missing parasternal view (Table 3).
The subcostal view was available in 371 participants
(60.4%), 48 of whom had not been adequately imaged from
the parasternal approach. Therefore, measures of left ven-
tricular cavity and wall thicknesses were available from the
subcostal view in 65.8% (48/73) of participants who could
not be imaged from the parasternal view (Fig. 1). Body mass
index or waist circumference were the only bivariate pre-
dictors of missing subcostal left ventricular mass values
(Table 2).
3.1. Parasternal and subcostal estimates of left ventricular
mass
Interobserver reproducibility of echocardiographic read-
ings was assessed in the first 109 participants. No significant
difference was observed between two readers (MDB, RP)
for septum and free wall thickness. Mean values of left
ventricular diastolic dimension were slightly different (meanTable 3






Age (years) 65–74 1.0 –
75–84 1.4 0.8, 2.6
z85 6.4 2.9, 14.1*
p for trend = 0.001
Male gender No 1.0 –
Yes 1.0 0.5, 2.1
< 90 1.0 –
Waist circumference (cm) 90–99 1.9 0.9, 3.8
z99 3.1 1.5, 6.2**
p for trend = 0.003
Current/past smoking No 1.0 –
Yes 2.7 1.3, 5.6***
The presence of obstructive lung physiology was backward deleted from
the initial model.
*p< 0.001 vs. first tertile.
**p= 0.002 vs. first tertile.
***p= 0.007 vs. No.error 0.8 mm, p = 0.029) between the two readings. How-
ever, this did not affect the estimates of left ventricular mass,
which were comparable between the two readers.
Left ventricular imaging was adequate from both the
parasternal and subcostal views in 323 participants. Overall,
left ventricular mass was underestimated from the subcostal
view [subcostal: 79.7 (1.3) vs. parasternal: 93.3 (1.5) g/m2;
p < 0.001], which was only 33% sensitive (24/73 cases) and
99% specific (247/250), as compared to the parasternal
view, in the diagnosis of left ventricular hypertrophy. Such
underestimation persisted even after restricting the compar-
ison to the 282 participants who were in sinus rhythm and
had no left ventricular wall motion abnormalities [subcostal:
76.7 (1.3) vs. parasternal: 90.2 (1.5) g/m2; p < 0.001], with a
sensitivity as low as 25% (14/55 cases) and unchanged
specificity (225/227, 99%) for the diagnosis of left ventric-
ular hypertrophy. This difference originated mainly from an
underestimation of left ventricular diastolic dimension,
whereas septum and free wall thicknesses from the two
views were comparable (Fig. 2).
Multivariate regression models were built from measure-
ments obtained in the randomly selected 146 participants
assigned to the equation development subgroup, in order to
improve the prediction of left ventricular mass using data
obtained from the subcostal view. A first set of equations was
developed on the direct prediction of left ventricular mass,
following a hierarchical approach for entering potentialTable 4
Prediction of parasternal left ventricular mass from echocardiographic data
obtained from the subcostal view in 146 participants of the equation
development subgroup
Model no. (n) Variables* R2 p Value
1 (146) Subcostal LV mass 0.52 < 0.001
2 (146) Model 1 +weight 0.54 < 0.001
3 (146) Model 2 + subcostal LV mass squared 0.56 < 0.001
4 (133)** Model 3 + FVC 0.59 < 0.001
LV: left ventricular; FVC: forced vital capacity; FEV1: forced expiratory
volume in 1 s. Spirometric variables expressed as percent of their predicted
values [25].
*Variables entered and stepwise deleted were: in Step 2, age and
gender; in Step 4, FEV1 and FEV1/FVC.
**Case number in Model 4 is less than in other models due to
unavailability of spirometric data in 13 participants.
Fig. 3. Regression of the difference between observed (from parasternal
view) and predicted (from subcostal view) left ventricular mass on observed
left ventricular mass, in the cross-validation subgroup (n= 130).
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ventricular mass alone explained 52% of the variance of
parasternal left ventricular mass. The progressive inclusion
of body weight (Model 2), a squared term for subcostal left
ventricular mass (Model 3), and FVC (Model 4) increased
the explained variance only marginally. Age, gender, height,
FEV1, and FEV1/FVC were not retained in any model. The
substitution of waist circumference for weight, or of body
mass index for height and weight, did not substantially
improve the amount of explained variance. When the model
providing the highest R2 (Model 4) was applied to the
participants in the cross-validation subgroup, the predicted
value correlated moderately well with that obtained from the
parasternal view (r = 0.67). However, the 95% confidence
interval for the slope (b = 0.80, 95% confidence interval:
0.65, 0.95) and the intercept (a = 19.6, 95% confidence
interval: 5.9, 33.3) of the regression equation did not include
one and zero, respectively, indicating that the regression was
diverging significantly from the line of identity. Furthermore,
the predicted left ventricular mass value substantially and
systematically underestimated the observed value, as shown
by a significant correlation between the difference of the two
estimates and the observed parasternal value (Fig. 3).
The alternative approach of modeling left ventricular
diastolic dimension using the subcostal measure, again with
sequential inclusion of several potential covariates, did not
improve the accuracy of the prediction of left ventricular
mass, recalculated with the adjusted left ventricular dimen-
sion value. The variance of parasternal left ventricular
dimension explained by regression models respectively
not adjusted and fully adjusted as previously described,
ranged from 42% to 51%. Left ventricular mass calculated
from predicted left ventricular dimension values still sub-
stantially underestimated parasternal left ventricular mass,
and did not improve the results illustrated in Fig. 3.4. Discussion
Echocardiographic estimates of left ventricular mass
were achieved from the parasternal view in 88% of our
community-dwelling older persons. This figure is higher
than usually reported in previous studies [10,11], includingCHS, where only 66% of participants had a valid left
ventricular mass estimate. Since body size is a major
determinant of successful echocardiographic imaging, our
results may derive from a lower proportion of overweight
participants in the present study sample. Yet, even in such a
thinner population, several factors, such as older age, larger
body size, and smoking habit systematically reduced the
availability of left ventricular mass from the parasternal
approach. This confirms the presence of a selection bias in
the echocardiographic assessment of left ventricular mass
and hypertrophy in older persons. Differently from CHS,
other factors, such history of coronary artery disease, were
not associated with the unavailability of parasternal view.
However, this difference with previous findings should be
interpreted cautiously, as our sample size may be under-
powered to detect these associations.
Devereux et al. [21] recently reported that left ventricular
mass was immeasurable in 9% of 3501 participants in the
Strong Heart Study, aged 45–74 years. Even with such a
low proportion of cases with unavailable left ventricular
mass, missing data was confirmed to be non-randomly
associated with several clinical characteristics, such as more
advanced age, larger body mass index, and poorer spiro-
metric performance. In that study, it was reassuring that the
proportion of incident cardiovascular events in the follow-
up was independent of the availability of left ventricular
mass measurements. However, this finding might not be
generalizable to older individuals, such as those included in
the sample enrolled in the present study.
The subcostal view is frequently available also in older
persons with poor acoustic accessibility from the parasternal
view [14]. However, standard formulas to calculate left
ventricular mass have been validated anatomically only
for linear M-mode measures taken from the parasternal
view [26]. In the ICARe Dicomano study, an attempt at
imaging the left ventricular from the subcostal view was
systematically performed independent of the availability of
the parasternal view. This allowed for an unbiased evalua-
tion of the usefulness of the subcostal approach in the
assessment of left ventricular mass.
An adequate subcostal view was obtained in a substan-
tially lower percentage of subjects (60%) than the para-
sternal view, including more than 65% (48/73) of the
participants who could not be imaged from the parasternal
approach. The availability of an adequate subcostal view
was unrelated to factors such as age and smoking, therefore
possibly reducing the selection bias in estimating left
ventricular mass. This prompted us to validate left ventric-
ular mass estimates from subcostal view.
Previous validation studies were limited to small, select-
ed series of younger individuals and reported conflicting
findings [15,16]. The results of the present study, which
enrolled a large sample of unselected older persons, indi-
cated that left ventricular mass from the subcostal approach
was substantially underestimated, even when the analysis
was restricted to participants without arrhythmias and left
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the sensitivity of the subcostal view in the diagnosis of left
ventricular hypertrophy was very poor. These negative
findings were marginally mitigated by the fact that septum
and free wall thickness was not statistically different
between the parasternal and the subcostal approaches,
therefore suggesting that the latter might be occasionally
used to replace a missing thickness measure from the
parasternal view.
Body size and shape affect the orientation of the ultra-
sound beam, thereby contributing to the poor agreement
between measures of the same cardiac structure from the
parasternal and subcostal approaches. Indeed, measures of
body size and shape, as well as of lung physiology, were
significant covariates in predicting parasternal left ventric-
ular mass from the subcostal view. However, the explained
variance was less than 60% and, most importantly, a
systematic error was detected in the prediction (Fig. 3).
This error was not reduced when the correction was alter-
natively based on adjustment of left ventricular dimension
from the subcostal view, followed by recalculation of left
ventricular mass.
Strengths of the present study are its population-based
design, the systematic attempts at visualizing the left ven-
tricular chamber from both parasternal and subcostal views,
and the availability of numerous, prospectively acquired
demographic and clinical measures, permitting an adjust-
ment for a broad spectrum of potential covariates. Despite
this, we were unable to obtain a satisfactory prediction of
left ventricular mass based on subcostal measures, even
after a complex adjustment procedure. As a study limitation,
we must acknowledge that better echocardiographic equip-
ments and newer technologies, or adjustment for other
variables not available in our database, might improve such
prediction.
Our findings have clear implications for epidemiological
studies of older populations, but they should be considered
also in the clinical setting. Echocardiography, indeed, is
frequently used to assess the presence of left ventricular
hypertrophy as an end-organ damage, or to evaluate the
effect of treatment, in patients with high blood pressure.
According to our results, estimates of left ventricular mass
obtained from the subcostal view are often inaccurate and
cannot validly substitute for a missing parasternal view.
When assessment of left ventricular mass has a high clinical
relevance and cannot be obtained from the parasternal view,
other techniques, such as magnetic resonance imaging,
should be probably considered [13].
In conclusion, our findings indicate that inclusion of the
subcostal view as currently performed would not increase
the yield, or improve the accuracy, of echocardiographic
estimation of left ventricular mass in epidemiological
studies of older populations. These findings give a strong
evidence-based support to the ASE recommendations,
which were issued only on a consensus basis, to the use
of the parasternal view as the only approach to quantitateleft ventricular mass [5]. These limitations of echocardi-
ography should be considered in studies on the epidemi-
ology of left ventricular hypertrophy and of its associated
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